Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels

Micale, Vincenzo, Cristino, Luigia, Tamburella, Alessandra, Petrosino, Stefania, Leggio, Gian Marco, Drago, Filippo, Di Marzo, Vincenzo·2009·Neuropsychopharmacology

Cited by (209)

Items 101–200 of 209

  1. Impaired brain endocannabinoid tone in the activity‐based model of anorexia nervosa
    Roberto Collu, María Scherma, Fabiana Piscitelli, Elisa Giunti, Valentina Satta, M. Paola Castelli, Roberta Verde, Walter Fratta, Tiziana Bisogno, Paola Fadda · 2019 · International Journal of Eating Disorders
  2. Novel investigational therapeutics for panic disorder
    Giampaolo Perna, Koen R.J. Schruers, Alessandra Alciati, Daniela Caldirola · 2014 · Expert Opinion on Investigational Drugs
  3. A dual inhibitor of FAAH and TRPV1 channels shows dose-dependent effect on depression-like behaviour in rats
    Christian Kirkedal, Gregers Wegener, Fabrício A. Moreira, Sâmia R.L. Joca, Nico Liebenberg · 2016 · Acta Neuropsychiatrica
  4. TRP Channels and Psychiatric Disorders
    Loris A. Chahl · 2010 · Advances in experimental medicine and biology
  5. Study the Effect of Endocannabinoid System on Rat Behavior in Elevated Plus-Maze.
    Alireza Komaki‬, Nasrin Hashemi-Firouzi, Shiva Shojaei, Zobin Souri, Somayeh Heidari, ‬Siamak Shahidi · 2015 · Europe PMC (PubMed Central)
  6. Anxiogenic-like effect induced by TRPV1 receptor activation within the dorsal periaqueductal gray matter in mice
    Diego Cardozo Mascarenhas, Karina Santos Gomes, Ricardo Luiz Nunes‐de‐Souza · 2013 · Behavioural Brain Research
  7. Supraspinal Transient Receptor Potential Subfamily V Member 1 (TRPV1) in Pain and Psychiatric Disorders
    Manish K. Madasu, Michelle Roche, David P. Finn · 2015 · Modern trends in psychiatry
  8. Exploração farmacológica do sistema endocanabinoide: novas perspectivas para o tratamento de transtornos de ansiedade e depressão?
    Viviane M. Saito, Carsten Tobias Wotjak, Fabrício A. Moreira · 2010 · Brazilian Journal of Psychiatry
  9. Synthesis of Linoleoyl Ethanolamide
    Xiaosan Wang, Yan Chen, Qingzhe Jin, Jianhua Huang, Xingguo Wang · 2013 · Journal of Oleo Science
  10. Behavioral effects of fatty acid amide hydrolase inhibition on morphine withdrawal symptoms
    ‬Siamak Shahidi, Parisa Hasanein · 2011 · Brain Research Bulletin
  11. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain
    Natalia Małek, Magdalena Kostrzewa, Wioletta Makuch, Agnieszka Pajak, Mateusz Wojciech Kucharczyk, Fabiana Piscitelli, Barbara Przewłocka, Vincenzo Di Marzo, Katarzyna Starowicz · 2016 · Pharmacological Research
  12. Role of TRPV1 receptors on panic-like behaviors mediated by the dorsolateral periaqueductal gray in rats
    Ana F. Almeida‐Santos, Fabrício A. Moreira, Francisco Silveira Guimarães, Daniele Cristina de Aguiar · 2013 · Pharmacology Biochemistry and Behavior
  13. Synthesis, physicochemical characterization and membrane interactions of a homologous series of N-acylserotonins: Bioactive, endogenous conjugates of serotonin with fatty acids
    S. Thirupathi Reddy, Musti Joginadha Swamy · 2014 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  14. Docosahexaenoyl serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23–IL-17 signaling in macrophages
    Mieke Poland, Jean Paul ten Klooster, Zheng Wang, Raymond H. H. Pieters, Mark V. Boekschoten, Renger F. Witkamp, Jocelijn Meijerink · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  15. Anticonvulsant Effects ofN‐Arachidonoyl‐Serotonin, a Dual Fatty Acid Amide Hydrolase Enzyme and Transient Receptor Potential Vanilloid Type‐1 ( TRPV 1) Channel Blocker, on Experimental Seizures: The Roles of Cannabinoid CB 1 Receptors and TRPV 1 Channels
    Luciano Vilela, Daniel de Castro Medeiros, Antônio Carlos Pinheiro de Oliveira, Márcio Flávio Dutra Moraes, Fabrício A. Moreira · 2014 · Basic & Clinical Pharmacology & Toxicology
  16. The interactive role of CB1 receptors and L-type calcium channels in hippocampal long-term potentiation in rats
    Hamidreza Komaki, Fargol Saadat, ‬Siamak Shahidi, Abdolrahman Sarihi, Parisa Hasanein, Alireza Komaki‬ · 2017 · Brain Research Bulletin
  17. Inhibition of the fatty acid amide hydrolase changes behaviors and brain catecholamines in a sex-specific manner in rats exposed to chronic unpredictable stress
    Milica Janković, Nataša Spasojević, Harisa Ferizović, Bojana Stefanović, Sladjana Dronjak · 2020 · Physiology & Behavior
  18. Synthesis and Evaluation of Paracetamol Esters As Novel Fatty Acid Amide Hydrolase Inhibitors
    Valentina Onnis, Cenzo Congiu, Emmelie Björklund, Franziska Hempel, Emma Söderström, Christopher John Fowler · 2010 · Journal of Medicinal Chemistry
  19. Effects of cannabinoid and vanilloid receptor agonists and their interaction on learning and memory in rats
    Mariam Shiri, Alireza Komaki‬, Shahrbanoo Oryan, Masoumeh Taheri Azandaryani, Hamidreza Komaki, Farshid Etaee · 2016 · Canadian Journal of Physiology and Pharmacology
  20. Cannabinoids induce apathetic and impulsive patterns of choice through CB1 receptors and TRPV1 channels
    Zahra Fatahi, Zahra Reisi, Gregor Rainer, Abbas Haghparast, Abbas Khani · 2018 · Neuropharmacology
  21. Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link?
    Manoela V. Fogaça, Ismael Galve‐Roperh, Francisco Silveira Guimarães, Alline Cristina Campos · 2013 · Current Neuropharmacology
  22. Low anandamide doses facilitate male rat sexual behaviour through the activation of CB1 receptors
    Ana Canseco-Alba, Gabriela Rodrı́guez–Manzo · 2014 · Psychopharmacology
  23. Effect of endocannabinoids on IgE-mediated allergic response in RBL-2H3 cells
    Jae‐Myung Yoo, Dai‐Eun Sok, Mee Ree Kim · 2013 · International Immunopharmacology
  24. The potential value of capsaicin in modulating cognitive functions in a rat model of streptozotocin-induced Alzheimer’s disease
    Manal Aly Shalaby, Howaida A. Nounou, Maha M. Deif · 2019 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
  25. Biphasic effects of anandamide on behavioural responses
    Gabriela Rodrı́guez–Manzo, Ana Canseco-Alba · 2015 · Behavioural Pharmacology
  26. Impairment of opiate‐mediated behaviors by the selective TRPV1 antagonist SB366791
    Shi‐Xun Ma, Seung‐Hwan Kwon, Jee‐Yeon Seo, Ji‐Young Hwang, Sa‐Ik Hong, Hyoung‐Chun Kim, Seok‐Yong Lee, Choon‐Gon Jang · 2016 · Addiction Biology
  27. Transient receptor potential vanilloid 1 channels modulate the anxiolytic effect of diazepam
    Shyamshree S.S. Manna, Sudhir Niranjanrao Umathe · 2011 · Brain Research
  28. Anti-Inflammatory and Antioxidant Actions of N-Arachidonoyl Serotonin in RAW264.7 Cells
    Hye Lyun Jeon, Jae‐Myung Yoo, Bo Dam Lee, Su Jin Lee, Eun Jung Sohn, Mee Ree Kim · 2016 · Pharmacology
  29. Cannabinoids, TRPV and nitric oxide: the three ring circus of neuronal excitability
    Giuditta Gambino, Valerio Rizzo, Giuseppe Giglia, Giuseppe Ferraro, Pierangelo Sardo · 2019 · Brain Structure and Function
  30. Paracetamol potentiates the antidepressant-like and anticompulsive-like effects of fluoxetine
    S. S. Manna, S. Umathe · 2015 · Behavioural Pharmacology
  31. Transient receptor potential vanilloid 3 (TRPV3) in the ventral tegmental area of rat: Role in modulation of the mesolimbic-dopamine reward pathway
    Uday Singh, Santosh Kumar, Gajanan P. Shelkar, Manoj Yadav, Dadasaheb M. Kokare, Chandan Goswami, Ronald M. Lechan, Praful S. Singru · 2016 · Neuropharmacology
  32. Selective inhibition of monoacylglycerol lipase is associated with passive coping behavior and attenuation of stress-induced dopamine release in the medial prefrontal cortex
    Francisco Javier Pavón, Ilham Y. Polis, David G. Stouffer, Benjamin F. Cravatt, Marisa Roberto, Rémi Martin‐Fardon, Fernando Rodrı́guez de Fonseca, Loren H. Parsons, Antonia Serrano · 2021 · Neurobiology of Stress
  33. Increased expression of cannabinoid receptor 1 in the nucleus accumbens core in a rat model with morphine withdrawal
    Wei‐Xin Yuan, Lijun Heng, Jie Ma, Xing-qin Wang, Li-Juan Qu, Li Na Duan, Jun‐Jun Kang, Liang-Wei Chen, Guodong Gao · 2013 · Brain Research
  34. Inhibition of FAAH, TRPV1, and COX2 by NSAID–serotonin conjugates
    Tyler M. Rose, Christopher A. Reilly, Cassandra E. Deering‐Rice, Clinton Brewster, Chelsea Brewster · 2014 · Bioorganic & Medicinal Chemistry Letters
  35. Pharmacological inhibition of FAAH activity in rodents: A promising pharmacological approach for psychological—cardiac comorbidity?
    Luca Carnevali, Silvia Rivara, Eugene Nalivaiko, Julian Francis Thayer, Federica Vacondio, Marco Mor, Andrea Sgoifo · 2016 · Neuroscience & Biobehavioral Reviews
  36. CB 1 receptor signalling mediates cannabidiol-induced panicolytic-like effects and defensive antinociception impairment in mice threatened by Bothrops jararaca lancehead pit vipers
    Bruno Mangili de Paula Rodrigues, Norberto Cysne Coimbra · 2022 · Journal of Psychopharmacology
  37. Repeated oral administration of capsaicin increases anxiety-like behaviours with prolonged stress-response in rats
    Y-J Choi, JY Kim, SB Yoo, J-H Lee, Jeong Won Jahng · 2013 · Journal of Biosciences
  38. The Enteric Glia and Its Modulation by the Endocannabinoid System, a New Target for Cannabinoid-Based Nutraceuticals?
    Laura López‐Gómez, Agata Szymaszkiewicz, Marta Zielińska, Raquel Abalo · 2022 · Molecules
  39. Cannabinoid Receptor Type 1 in the Brain Regulates the Affective Component of Visceral Pain in Mice
    Danica Bajic, Krisztina Monory, Andrea Conrad, Christina Maul, Roland Michael Schmid, Carsten Tobias Wotjak, Christoph K. Stein‐Thoeringer · 2018 · Neuroscience
  40. Arachidonoyl serotonin (AA-5-HT) modulates general fear-like behavior and inhibits mesolimbic dopamine release
    Timothy G. Freels, Deranda B. Lester, Melloni N. Cook · 2019 · Behavioural Brain Research
  41. Red-hot chili receptors: A systematic review of TRPV1 antagonism in animal models of psychiatric disorders and addiction
    Andrea Escelsior, Bruno Sterlini, Martino Belvederi Murri, Gianluca Serafini, Andrea Aguglia, Beatriz Pereira da Silva, Anna Margherita Corradi, Pierluigi Valente, Mario Amore · 2020 · Behavioural Brain Research
  42. Spontaneous and Naloxone-Precipitated Withdrawal Behaviors From Chronic Opiates are Accompanied by Changes in N-Oleoylglycine and N-Oleoylalanine Levels in the Brain and Ameliorated by Treatment With These Mediators
    Samantha M. Ayoub, Fabiana Piscitelli, Cristoforo Silvestri, Cheryl L. Limebeer, Erin M. Rock, Reem Smoum, Mathew Farag, Hannah de Almeida, Megan T. Sullivan, Sébastien Lacroix et al. · 2021 · Frontiers in Pharmacology
  43. Endocannabinoidome
    Iannotti Fabio Arturo, Fabiana Piscitelli · 2018 · Encyclopedia of Life Sciences
  44. Visualization by high resolution immunoelectron microscopy of the transient receptor potential vanilloid-1 at inhibitory synapses of the mouse dentate gyrus
    Canduela, Miren-Josune, Mendizabal-Zubiaga, Juan, Puente, Nagore, Reguero, Leire, Elezgarai, Izaskun, Ramos-Uriarte, Almudena, Gerrikagoitia, Inmaculada, Grandes, Pedro · 2015 · PLoS ONE
  45. TRPV1 modulation of contextual fear memory depends on stimulus intensity and endocannabinoid signalling in the dorsal hippocampus
    Lia P. Iglesias, Heliana de Barros Fernandes, Aline Silva de Miranda, Malena M. Pérez, Lúcia Helena Faccioli, Carlos A. Sorgi, Leandro Jose Bertoglio, Daniele Cristina de Aguiar, Carsten Tobias Wotjak, Fabrício A. Moreira · 2022 · Neuropharmacology
  46. Expression of the Transient Receptor Potential Vanilloid 1 ion channel in the supramammillary nucleus and the antidepressant effects of its antagonist AMG9810 in mice
    Khai Huynh Ngoc, Angéla Kecskés, Eszter Kepe, Liza Nabi, Julie Elizabeth Keeble, Éva Borbély, Zsuzsanna Helyes · 2023 · European Neuropsychopharmacology
  47. Parkinson’s disease related alterations in cannabinoid transmission
    Monavareh Soti, Hoda Ranjbar, Kristi A. Kohlmeier, Mohammad Shabani · 2021 · Brain Research Bulletin
  48. Placebo Effects in a Multiple Sclerosis Spasticity Enriched Clinical Trial with the Oromucosal Cannabinoid Spray ( THC / CBD ): Dimension and Possible Causes
    Vincenzo Di Marzo, Diego Centonze · 2014 · CNS Neuroscience & Therapeutics
  49. CB1 cannabinoid receptor-mediated anandamide signaling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy
    Priscila Sanjuan de Medeiros, Renato Leonardo de Freitas, M.O. Silva, Norberto Cysne Coimbra, Liana Melo-Thomas · 2016 · Neuroscience
  50. Interaction between Cannabinoid Compounds and Capsazepine in Protection against Acute Pentylenetetrazole-induced Seizure in Mice.
    Nima Naderi, Effat Shafieirad, Delaram Lakpoor, Atena Rahimi, Zahra Mousavi · 2015 · PubMed Central
  51. 2-Arachidonoylglycerol endocannabinoid signaling coupled to metabotropic glutamate receptor type-5 modulates anxiety-like behavior in the rat ventromedial prefrontal cortex
    Ana F. Almeida‐Santos, Fabrício A. Moreira, Francisco Silveira Guimarães, Daniele Cristina de Aguiar · 2017 · Journal of Psychopharmacology
  52. A Novel Bio-Psychosocial-Behavioral Treatment Model of Panic Disorder
    Seon‐Cheol Park, Yong‐Ku Kim · 2018 · Psychiatry Investigation
  53. TRPV1 and mast cell involvement in repeated variate stress-induced urinary bladder dysfunction in adult female mice
    Amanda B. Sidwell, Beatrice M. Girard, Susan E. Campbell, Margaret A. Vizzard · 2024 · American Journal of Physiology-Renal Physiology
  54. The endocannabinoidome–gut microbiome–brain axis as a novel therapeutic target for autism spectrum disorder
    Antonella Campanale, Dario Siniscalco, Vincenzo Di Marzo · 2025 · Journal of Biomedical Science
  55. TRP Channels in Neuronal and Glial Signal Transduction
    Christian Harteneck, Kristina Leuner · 2014 · InTech eBooks
  56. Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats
    Alexandre Seillier, Andrea Giuffrida · 2011 · Pharmacology Biochemistry and Behavior
  57. ΒN-Alkanoyl-5-Hydroxytryptamines (Cn-5HTs) in Coffee: A Review
    Ana Laura Macedo Brand, Fernanda Alves Lima, Natália A. B. Tinoco, José Carlos F. Mota, I. G. S. Moreira, Fábio Júnior Moreira Novaes, Rafael Garrett, Thaís Biondino Sardella Giorno, Patrícia Dias Fernandes, Cláudia M. Rezende · 2022 · Food Reviews International
  58. Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack
    Luara A. Batista, Andréa Siqueira Haibara, Luiz Carlos Schenberg, Fabrício A. Moreira · 2016 · Behavioural Brain Research
  59. Cannabinoid CB1 and Cholecystokinin CCK2 Receptors Modulate, in an Opposing Way, Electrically Evoked [3H]GABA Efflux from Rat Cerebral Cortex Cell Cultures: Possible Relevance for Cortical GABA Transmission and Anxiety
    Tiziana Antonelli, Maria Cristina Tomasini, Roberta Mazza, Kjell Fuxé, Silvana Gaetani, V. Cuomo, Sergio Tanganelli, Luca Ferraro · 2009 · Journal of Pharmacology and Experimental Therapeutics
  60. Anti‐Apoptotic Effect of N‐Palmitoyl Serotonin on Glutamate‐Mediated Apoptosis Through Secretion of BDNF and Activation of TrkB/CREB Pathway in HT‐22 Cells
    Jae‐Myung Yoo, Bo Dam Lee, Su Jin Lee, Jin Yeul, Mee Ree Kim · 2017 · European Journal of Lipid Science and Technology
  61. CB1 receptor signaling: Linking neuroplasticity, neuronal types, and mental health outcomes
    Qianqian Gao, Muhammad Asim · 2025 · Neurochemistry International
  62. Unravelling a potential therapeutic effect of polymeric lipid-core nanoencapsulated cannabidiol on anxiety- and panic-like behaviours elicited by Bothrops jararaca lancehead pit vipers
    Bruno Mangili de Paula Rodrigues, Paloma Molina Hernandes, Rafael Canalle Balvedi, Hígor Ferreira Martins Alves, Karoline Paiva da Silva, Rogério de Campos Bicudo, Marcelo Jung Eberhardt, Fernanda S. Poletto, Karina Paese, Sı́lvia Stanisçuaski Guterres et al. · 2025 · International Journal of Pharmaceutics
  63. Endocannabinoid Metabolism and Transport as Drug Targets
    Francesca Ciaramellano, Federico Fanti, Lucia Scipioni, Mauro Maccarrone, Sergio Oddi · 2022 · Methods in molecular biology
  64. Cannabinoids and Motor Control of the Basal Ganglia: Therapeutic Potential in Movement Disorders
    Teresa Morera‐Herreras, Cristina Miguélez, Asier Aristieta, Marı́a Torrecilla, José Ángel Ruíz-Ortega, Luisa Ugedo · 2016 · InTech eBooks
  65. Dual effects of anandamide in the antiepileptic activity of diazepam in pentylenetetrazole-induced seizures in mice
    Shyamshree S.S. Manna · 2022 · Behavioural Pharmacology
  66. The Endocannabinoid System as a Target for New Antiseizure Drugs
    Luciano Vilela, Antônio Carlos Pinheiro de Oliveira, Márcio Flávio Dutra Moraes, Fabrício A. Moreira, Reinaldo Naoto Takahashi · 2017 · Elsevier eBooks
  67. Therapeutic potential of transient receptor potential (TRP) channels in psychiatric disorders
    Veerta Sharma, Prateek Sharma, Thakur Gurjeet Singh · 2024 · Journal of Neural Transmission
  68. Antinociceptive Effect of Dendrobii caulis in Paclitaxel-Induced Neuropathic Pain in Mice
    Keun-Tae Park, Yong Jae Jeon, Hyo In Kim, Woojin Kim · 2023 · Life
  69. Blockade of the endovanilloid receptor, TRPV1, and of the endocannabinoid enzyme, FAAH, within the nucleus accumbens shell elicits anxiolytic-like effects in male rats
    Thibaut R. Pardo-García, Nadira Yusif-Rodriguez, Guillermo Ariel Yudowski, Carmen S. Maldonado-Vlaar · 2020 · Neuroscience Letters
  70. N-Acyldopamines and N-Acylserotonins: From Synthetic Pharmacological Tools to Endogenous Multitarget Mediators
    Luciano De PETROCELLIS, Vincenzo Di Marzo · 2014 · Elsevier eBooks
  71. Developing a functional non-animal CNS stress model utilizing long-term potentiation with human iPSC-cortical neurons to evaluate therapeutics
    Kaveena Autar, Xiufang Guo, Haley Powell, Aakash Patel, Mridu Malik, Marcella Grillo, Nesar Akanda, Narasimhan Sriram Narasimhan, Will Bogen, Christopher J. Long et al. · 2025 · Biomedicine & Pharmacotherapy
  72. Interaction Between L-Type Calcium Channels and Antagonist of Cannabinoid System on Anxiety in Male Rat
    Alireza Komaki‬, Aezam Haghgooyan, ‬Siamak Shahidi, Abdolrahman Sarihi, Iraj Salehi · 2014 · Avicenna Journal of Neuro Psych Physiology
  73. Bridging the gap: The endocannabinoid system as a functional fulcrum for benzodiazepines in a novel frontier of anxiety pharmacotherapy.
    Sina Pakkhesal, Mohammad Shakouri, R. Mosaddeghi-Heris, Sepideh Kiani Nasab, Negin Salehi, Amir Mohammad Sharafi, A. Ahmadalipour · 2025 · Pharmacology and Therapeutics
  74. Endocannabinoid-Dependent Synaptic Plasticity in the Striatum
    Brady K. Atwood, David M. Lovinger · 2017 · Springer eBooks
  75. Cannabinoid-Based Medicine: Pharmacology and Drug Interactions
    Mellar P. Davis · 2022 · Springer eBooks
  76. Involvement of the Endocannabinoid System in the pathophysiology and therapeutics of movement disorders
    Aldo Rafael Tejeda-Martínez, Juan Manuel Viveros Paredes, Mario Eduardo Flores-Soto · 2022 · Neurology Perspectives
  77. Enhancing anandamide signalling through fatty acid amide hydrolase inhibition: An update on the pharmacological strategy for treating psychiatric disorders
    Timothy A. Couttas, Anna Hoffmann, Beverly Jieu, Felix R. Golla, Claire E. Shepherd, F. Markus Leweke, Cathrin Rohleder · 2026 · Translational Psychiatry
  78. Temperature-Sensitive Transient Receptor Potential Channels as Ionotropic Cannabinoid Receptors
    Vincenzo Di Marzo, Luciano De PETROCELLIS · 2012 · The Receptors
  79. Indirect and direct cannabinoid agonists differentially affect mesolimbic dopamine release and related behaviors.
    Kevin M. Honeywell, Timothy G. Freels, Megan A. McWain, Abigail S. Chaffin, Hunter G. Nolen, Helen J.K. Sable, Deranda B. Lester · 2024 · Behavioral Neuroscience
  80. Cannabinoids and Levodopa-Induced Dyskinesia
    Andrea Giuffrida, Alex Anthony Martinez · 2014 · Springer eBooks
  81. The ever-expanding world of the endocannabinoids: A concise introduction
    Fabiana Piscitelli, Vincenzo Di Marzo · 2015 · Elsevier eBooks
  82. Anxiety
    Kylie O’Brien, Philip Blair · 2021 · Springer eBooks
  83. Investigating the role of the endogenous cannabinoid system in emotional modulation of pain: neurochemical and molecular mechanisms
    Weredeselam M. Olango · 2012 · Arrow@dit (Dublin Institute of Technology)
  84. Die Wirkungsweise der TRPV1-Kanäle auf die synaptische Plastizität im lateralen Kern der Amygdala
    Christoph Kulisch · 2014 · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver
  85. Impact of Cannabinoid Type 1 Receptor Modulation on Risky Decision-Making
    Timothy G. Freels, Anna E. Liley, Daniel B. K. Gabriel, Nicholas W. Simon · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  86. Kannabisaren terapiarako erabilera mugimenduaren asalduretan
    Teresa Morera‐Herreras, Cristina Miguélez, Asier Aristieta, José Ángel Ruíz-Ortega, Marı́a Torrecilla · 2013 · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria
  87. TRPV1 in Neuropathic Pain and Neurological and Neuropsychiatric Disorders
    Enza Palazzo, Katarzyna Starowicz, Sabatino Maione, Vincenzo Di Marzo · 2010 · Wiley eBooks
  88. Anatomical, Biochemical, and Behavioral Evidence for Cannabinoid Modulation of Noradrenergic Circuits: Role of Norepinephrine in Cannabinoid-Induced Aversion
    Ana Franky Carvalho, Elisabeth J. Van Bockstaele · 2013 · Springer eBooks
  89. Development and characterization of chronic animal models of schizophrenia
    Zita Petrovszki · 2015
  90. Envolvimento de vias mediadas por endocanabinoides na modulação do comportamento de defesa induzido pelo bloqueio de receptores GABAA na divisão dorso-medial do hipotálamo ventro-medial: papel do receptor CB1
    Tayllon dos Anjos‐Garcia · 2014
  91. Chronic pain and arthritis – studies of mechanisms in the regulation of hypersensitivity
    Jie Su · 2016 · Figshare
  92. Efeitos comportamentais do canabidiol em um modelo de psicose induzida por S(+)-ketamina em ratos Wistar
    Jana Batista De Ross · 2017
  93. TRPV1 regulates excitatory innervation of oriens lacunosum moleculare (OLM) neurons in the hippocampus to affect synaptic plasticity
    Joaquin I. Hurtado-Zavala · 2017
  94. Possível interação entre os sistemas endocanabinóide, glutamatérgico e nitrérgico do CPFmv na modulação de respostas emocionais/comportamentais ao estresse
    Ariandra Guerini Sartim · 2018
  95. Mecanismos envolvidos no perfil antipsicótico do canabidiol
    João Francisco Cordeiro Pedrazzi · 2019
  96. Avaliação do efeito tipo-antidepressivo da aracdonoil serotonina (AA-5HT) no teste do nado forçado
    Kennia Moura Silveira · 2018
  97. Recrutamento de receptores canabinoides do tipo 1 (CB1) no efeito do canabidiol sobre as respostas defensivas inatas evocadas por camundongos ameaçados por jararacas
    Bruno Mangili de Paula Rodrigues · 2020
  98. Are Fatty Acid Amide Hydrolase Levels Elevated in Social Anxiety Disorder? Preliminary Findings of a PET Study using [C-11]CURB
    Mashal Ahmed · 2020 · TSpace (University of Toronto)
  99. Envolvimento dos receptores TRPV1 do hipocampo dorsal de ratos na modulação da resposta emocional condicionada: uma possível interação com os sistemas glutamatérgico, nitrérgico e da via GMPc
    Gabriela Bertacchini Luiz Spiacci · 2017
  100. Targeting TRP channels for anxiety relief and improving mental health
    ARPAD SZALLASI · 2024 · Elsevier eBooks